Analysis

The pharmaceutical giant Pfizer is navigating a challenging start to 2026, caught in a crossfire of financial, regulatory, and competitive...

Shares of Lynas Rare Earths opened the week on a positive note, closing at AUD 12.47 on Monday for a...

Adobe shares have faced significant headwinds this year, shedding nearly 30% of their value since January. This decline reflects mounting...

Following a period of significant volatility, shares of semiconductor specialist Wolfspeed have shown initial signs of stabilization this December. A...

Shares of industrial conglomerate Textron are trading near their highest levels of the year, buoyed by a fresh government contract...

Intellia Therapeutics finds itself in a challenging phase as regulatory delays for a key drug candidate trigger a wave of...

Shares of drone technology firm Red Cat Holdings Inc. surged at the start of the week, propelled by a significant...

The journey from project planning to commercial production is a financial high-wire act for many junior mining companies. Standard Lithium...

The past year has presented UnitedHealth with its most severe market challenges since the 2008 financial crisis. The healthcare behemoth,...

As 2025 draws to a close, Bitcoin presents a complex picture of conflicting signals. While billions continue to enter the...